Skip to main content
4th of July Sale — Get 40% off Vantage subscriptions
Published loading...Updated

They Stop Covering a Remedy for Diabetes and in the Prepaid Argue that People Use It for Something Else.

Summary by Clarin
They claim that more than a thousand diabetic assumptions were “lazy papers.” It also became very difficult for them to accept coverage of new treatments.They adjust requirements that patients must meet for the benefit and there is controversy.

2 Articles

Lean Right

They claim that more than a thousand diabetic assumptions were “lazy papers.” It also became very difficult for them to accept coverage of new treatments.They adjust requirements that patients must meet for the benefit and there is controversy.

·Buenos Aires, Argentina
Read Full Article

Prepaid medicine companies began to harden the criteria for authorizing semaglutide coverage, a remedy used for type 2 diabetes, which also gained popularity for its effects on weight loss. Read more

·Buenos Aires, Argentina
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
4th of July SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Clarin broke the news in Buenos Aires, Argentina on Friday, July 3, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal